Diabetes-related ERECTILE DYSFUNCTION (ED)
For treatment of urogenital indications Flashwave® focuses on blood vessels and neovascularization in the penis shaft and crus, helping relieve vascular deficiency, a common cause of, among other things, erectile dysfunction.
Due to the design of the bespoke Diabetes CCI Flashwave® only has to be applied to one side of the penis or the crus, as it fully penetrates the tissue in the treatment area.
Erectile dysfunction (ED) is a sexual dysfunction that is increasingly prevalent with age. Men affected by ED are unable to develop or maintain an erection sufficient for sexual intercourse despite being sexually stimulated. Most ED cases are of vascular origin, with diabetes patients at a significantly higher risk of suffering these complications.
Unlike conventional ED treatment, such as PDE-5 inhibitors, Flashwave® does not involve the use of any pharmaceuticals. The non-invasive Flashwave® procedure is performed during a series of five treatments and requires no sedation or anesthesia.
Noticeable improvement may be visible within two weeks after start of the therapy. A high rate of patient satisfaction can be observed, all without reliance on PDE-5 inhibitors
or antibiotics. Flashwave® has shown significant long-term effectiveness. Vasculogenic and diabetic ED patients will
benefit from Flashwave® – those who are responsive to PDE-5 inhibitors as well as those who are unresponsive. For the latter group, which includes a substantial number of
severe ED patients, the only solution to date are vacuum pumps, injections and perhaps implants.
Flashwave® therapy not only offers a new treatment option, but brings hope to those patients, by allowing more than 70 % of them to become responsive to PDE-5 inhibitors. As »end-stage« ED patients, they will be able to enjoy normal sexual functionality. With over 50 % of men aged 40–70 suffering from ED, and even more from transient ED, Flashwave® therapy can bring improvement in erectile function and new sexual spontaneity to millions of patients in a safe and natural manner.
We recommend one treatment per week over a duration of five weeks.
If necessary, the treatment cycle can be repeated 8 weeks after the last treatment.